LATEST PRESS RELEASES

JUNE 11, 2024

IRLAB participates in Stora Aktiedagarna

Gothenburg, Sweden, June 11, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson’s disease, today announced that the company will give a presentation at Stora Aktiedagarna in Stockholm on June 11-12.

Read More >
MAY 28, 2024

IRLAB presents at Redeye Growth Day 30 May

Read More >
MAY 27, 2024 / REGULATORY

IRLAB appoints Kristina Torfgård as new CEO

Read More >

FINANCIAL CALENDAR

NEXT

July 10, 2024

Interim Report January – June 2024